Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.

Autor: Ji, Tongting¹ (AUTHOR), Yang, Yang² (AUTHOR), Yu, Juanjuan¹ (AUTHOR), Yin, Hongli² (AUTHOR), Chu, Xinran³ (AUTHOR), Yang, Pengju¹ (AUTHOR), Xu, Ling^1,4 (AUTHOR), Wang, Xiaodong⁵ (AUTHOR), Hu, Shaoyan³ (AUTHOR), Li, Yizhen² (AUTHOR), Wu, Xiaochen¹ (AUTHOR), Liu, Wengyuan⁶ (AUTHOR), Zhou, Bi^1,7 (AUTHOR), Wang, Wenjuan⁸ (AUTHOR), Zhang, Shuqi^1,9 (AUTHOR), Cheng, Wei^1,9 (AUTHOR), Chen, Yanling¹ (AUTHOR), Shi, Lei¹⁰ (AUTHOR), Li, Zhiheng² (AUTHOR), Zhuo, Ran¹ (AUTHOR)

Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 7/24/2024, Vol. 43 Issue 1, p1-22. 22p.